1 study found for:    Ustekinumab crohn's phase 3 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Conditions: Crohn's Disease;   Colitis;   IBD;   Inflammatory Bowel Disease
Interventions: Drug: Placebo;   Drug: Ustekinumab

Indicates status has not been verified in more than two years